Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is August - July.

Millions USD. Fiscal year is Aug - Jul.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 6, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021	Jul '20 Jul 31, 2020	2016 - 2020
Market Capitalization	20,292	12,458	7,120	3,394	7,621	4,428	Upgrade
Market Cap Growth	23.52%	74.97%	109.81%	-55.47%	72.09%	4.91%	Upgrade
Enterprise Value	19,907	12,193	7,087	3,494	7,543	4,336	Upgrade
Last Close Price	75.70	50.51	30.20	15.13	36.02	22.19	Upgrade
Forward PE	43.08	41.91	44.14	-	-	-	Upgrade
PS Ratio	8.16	5.80	3.82	2.15	5.47	3.39	Upgrade
PB Ratio	-	-17.11	-10.06	-4.24	-7.53	-16.10	Upgrade
P/FCF Ratio	26.47	20.84	34.40	183.59	-	-	Upgrade
P/OCF Ratio	23.97	18.51	26.14	50.24	-	-	Upgrade
EV/Sales Ratio	8.18	5.67	3.80	2.21	5.41	3.32	Upgrade
EV/EBITDA Ratio	91.64	127.49	-	-	-	-	Upgrade
EV/EBIT Ratio	135.04	471.97	-	-	-	-	Upgrade
EV/FCF Ratio	25.97	20.40	34.24	189.02	-	-	Upgrade
Debt / Equity Ratio	-2.10	-0.95	-1.88	-1.80	-1.18	-2.34	Upgrade
Debt / EBITDA Ratio	5.89	5.18	-	-	-	-	Upgrade
Debt / FCF Ratio	1.95	1.16	6.43	78.00	-	-	Upgrade
Asset Turnover	0.83	0.92	0.76	0.68	0.69	0.74	Upgrade
Quick Ratio	1.69	0.99	1.41	1.25	1.51	1.29	Upgrade
Current Ratio	1.88	1.19	1.64	1.43	1.68	1.44	Upgrade
Return on Assets (ROA)	3.14%	0.69%	-4.30%	-12.34%	-20.46%	-29.13%	Upgrade
Return on Capital (ROIC)	11.88%	5.48%	-16.66%	-69.67%	-150.52%	-102.08%	Upgrade
Return on Capital Employed (ROCE)	8.10%	2.90%	-	-	-	-	Upgrade
Earnings Yield	0.12%	-1.00%	-3.57%	-23.54%	-13.59%	-19.71%	Upgrade
FCF Yield	3.78%	4.80%	2.91%	0.55%	-2.08%	-5.63%	Upgrade
Buyback Yield / Dilution	-16.28%	-4.93%	-5.77%	-6.81%	-6.04%	-7.56%	Upgrade

Updated May 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q